NSA2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.675900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.822600E-01
Normal-vs-Stage2
2.926000E-02
Normal-vs-Stage3
6.731600E-02
Normal-vs-Stage4
3.554000E-01
Stage1-vs-Stage2
6.200200E-01
Stage1-vs-Stage3
7.616100E-02
Stage1-vs-Stage4
9.892500E-02
Stage2-vs-Stage3
2.039800E-01
Stage2-vs-Stage4
2.827200E-01
Stage3-vs-Stage4
4.128500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.448300E-02
Normal-vs-AfricanAmerican
1.378980E-01
Normal-vs-Asian
1.677990E-03
Caucasian-vs-AfricanAmerican
5.331800E-01
Caucasian-vs-Asian
7.973000E-04
AfricanAmerican-vs-Asian
1.001610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.260200E-02
Normal-vs-Female
4.260200E-02
Male-vs-Female
8.903600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.402400E-01
Normal-vs-Age(41-60Yrs)
4.711900E-02
Normal-vs-Age(61-80Yrs)
2.342100E-02
Normal-vs-Age(81-100Yrs)
1.272600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.707200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.514600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.611000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.016840E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.376000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.906400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.076200E-03
Normal-vs-Daily Drinker
6.926100E-02
Normal-vs-Weekly Drinker
8.776200E-03
Normal-vs-Occasional Drinker
2.189400E-01
Normal-vs-Social Drinker
3.932300E-02
Non Drinker-vs-Daily Drinker
3.731600E-01
Non Drinker-vs-Weekly Drinker
3.707200E-01
Non Drinker-vs-Occasional Drinker
4.879700E-02
Non Drinker-vs-Social Drinker
1.827580E-01
Daily Drinker-vs-Weekly Drinker
1.892350E-01
Daily Drinker-vs-Occasional Drinker
2.887400E-01
Daily Drinker-vs-Social Drinker
8.303200E-01
Weekly Drinker-vs-Occasional Drinker
2.826000E-02
Weekly Drinker-vs-Social Drinker
8.726200E-02
Occasional Drinker-vs-Social Drinker
3.784800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.880800E-01
Normal-vs-Grade 2
1.774190E-01
Normal-vs-Grade 3
1.169790E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.666200E-01
Grade 1-vs-Grade 3
5.718800E-01
Grade 1-vs-Grade 4
2.880800E-01
Grade 2-vs-Grade 3
3.923800E-01
Grade 2-vs-Grade 4
1.774190E-01
Grade 3-vs-Grade 4
1.169790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.500300E-02
Normal-vs-NonDiabetic
1.750370E-02
Diabetic-vs-NonDiabetic
3.582400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.576300E-02
Normal-vs-NoPancreatitis
2.129500E-02
Pancreatitis-vs-NoPancreatitis
5.256000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.154000E-02
Normal-vs-N1
2.388400E-02
N0-vs-N1
6.003600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.901600E-02
Normal-vs-TP53-NonMutant
1.139390E-01
TP53-Mutant-vs-TP53-NonMutant
2.128200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
